FibroBiologics Inc. Common Stock (FBLG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    FibroBiologics Inc. Commo...

    NASDAQ: FBLG · Real-Time Price · USD
    0.55
    0.00 (0.15%)
    At close: Oct 06, 2025, 3:32 PM

    FibroBiologics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 573K 437K 94K n/a
    Gross Profit
    		 -573K -437K -94K n/a
    Operating Income
    		 -13.74M -8.89M -4.47M -1.58M
    Interest Income
    		 251K n/a n/a n/a
    Pretax Income
    		 -11.16M -16.48M -5.12M -1.58M
    Net Income
    		 -11.16M -16.48M -5.12M -1.58M
    Selling & General & Admin
    		 9.23M 6.52M 3.23M 1.06M
    Research & Development
    		 4.5M 2.37M 1.15M 521K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 13.74M 8.89M 4.37M 1.58M
    Interest Expense
    		 20K 147K 654K 4K
    Selling & Marketing Expenses
    		 n/a 685K -94K n/a
    Cost & Expenses
    		 -13.74M 8.89M 4.47M 1.58M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 32.88M 32.49M 32.49M 32.49M
    Shares Outstanding (Diluted)
    		 32.88M 28.23M 32.49M 32.49M
    EPS (Basic)
    		 -0.34 -0.59 -0.16 -0.05
    EPS (Diluted)
    		 -0.34 -0.68 -0.16 -0.05
    EBITDA
    		 -13.74M -15.9M -4.37M -1.58M
    EBIT
    		 -11.18M -16.34M -4.47M -1.58M
    Depreciation & Amortization
    		 573K 437K 94K n/a

    Add to Watchlist